BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24135021)

  • 1. Role of IκB kinase-β in the growth-promoting effects of angiotensin II in vitro and in vivo.
    Doyon P; van Zuylen WJ; Servant MJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2850-7. PubMed ID: 24135021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.
    Lv P; Miao SB; Shu YN; Dong LH; Liu G; Xie XL; Gao M; Wang YC; Yin YJ; Wang XJ; Han M
    Circ Res; 2012 Aug; 111(6):697-707. PubMed ID: 22798525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
    Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T
    Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
    Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
    Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells.
    Hafizi S; Wang X; Chester AH; Yacoub MH; Proud CG
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1232-8. PubMed ID: 15317677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.
    Valente AJ; Yoshida T; Murthy SN; Sakamuri SS; Katsuyama M; Clark RA; Delafontaine P; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H282-96. PubMed ID: 22636674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.
    Moraes JA; Frony AC; Dias AM; Renovato-Martins M; Rodrigues G; Marcinkiewicz C; Assreuy J; Barja-Fidalgo C
    Atherosclerosis; 2015 Dec; 243(2):477-85. PubMed ID: 26520903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells.
    Doyon P; Servant MJ
    J Biol Chem; 2010 Oct; 285(40):30708-18. PubMed ID: 20659889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.
    Kim JS; Kim IK; Lee SY; Song BW; Cha MJ; Song H; Choi E; Lim S; Ham O; Jang Y; Hwang KC
    Cell Biol Int; 2012 Mar; 36(3):305-10. PubMed ID: 22050182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells.
    Haider UG; Sorescu D; Griendling KK; Vollmar AM; Dirsch VM
    Mol Pharmacol; 2002 Oct; 62(4):772-7. PubMed ID: 12237323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
    Won SM; Park YH; Kim HJ; Park KM; Lee WJ
    Exp Mol Med; 2006 Oct; 38(5):525-34. PubMed ID: 17079869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
    Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
    Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
    Allard EK; Grujic M; Fisone G; Kristensson K
    Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
    Chen J; Chen JK; Neilson EG; Harris RC
    J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
    Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
    J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells.
    Ishida M; Ishida T; Nakashima H; Miho N; Miyagawa K; Chayama K; Oshima T; Kambe M; Yoshizumi M
    Circ Res; 2003 Dec; 93(12):1218-24. PubMed ID: 14605021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel.
    Nishioka K; Nishida M; Ariyoshi M; Jian Z; Saiki S; Hirano M; Nakaya M; Sato Y; Kita S; Iwamoto T; Hirano K; Inoue R; Kurose H
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2278-86. PubMed ID: 21799177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.